Pharmacy Research Today is a free monthly online journal that collates and summarizes the latest research about Pharmacy, including details on drug stores, prescriptions, health care.

Volume 4 (2008), Issue 6 (June)

1. Stem Cells: Implications in Experimental Ischaemic Stroke Therapy.
   Stem Cell Rev. [Abstract] [Full-text]
2. The development of the Self-Medicating Scale (SMS): a scale to measure people's beliefs about self-medication.
   Pharm World Sci. [Abstract] [Full-text]
3. Solid Lipid Nanoparticles Enhance the Delivery of the HIV Protease Inhibitor, Atazanavir, by a Human Brain Endothelial Cell Line.
   Pharm Res. [Abstract] [Full-text]
4. In Vitro evaluation of the cytotoxic and anti-proliferative properties of resveratrol and several of its analogs.
   Cell Mol Biol Lett. [Abstract] [Full-text]
5. Impaired insulin-mediated vasorelaxation in a nonobese model of type 2 diabetes: role of endothelin-1.
   Can J Physiol Pharmacol, 86(6): 358-364. [Abstract] [Full-text]
6. Self-assembling multimeric integrin {alpha}5{beta}1 ligands for cell attachment and spreading.
   Protein Eng Des Sel. [Abstract] [Full-text]
7. Effects of bifeprunox and aripiprazole on rat serotonin and dopamine neuronal activity and anxiolytic behaviour.
   J Psychopharmacol. [Abstract] [Full-text]
8. N-Phthaloyl-glycine-hydroxamic acid as serum iron chelator in rats.
   Acta Pharm, 58(2): 233-238. [Abstract] [Full-text]
9. Gastric floating matrix tablets: Design and optimization using combination of polymers.
   Acta Pharm, 58(2): 223-231. [Abstract] [Full-text]
10. Studying the formation of aggregates in recombinant human granulocyte-colony stimulating factor (rHuG-CSF), lenograstim, using size-exclusion chromatography and SDS-PAGE.
    Acta Pharm, 58(2): 199-206. [Abstract] [Full-text]
11. Effect of various surfactants and their concentration on controlled release of captopril from polymeric matrices.
    Acta Pharm, 58(2): 151-162. [Abstract] [Full-text]
12. Dysregulation of neurosteroids in obsessive compulsive disorder.
    J Psychiatr Res. [Abstract] [Full-text]
13. Stereospecific high-performance liquid chromatographic assay of isosakuranetin in rat urine.
    J Chromatogr B Analyt Technol Biomed Life Sci. [Abstract] [Full-text]
14. Synthetic studies on glycosphingolipids from Protostomia phyla: syntheses and biological activities of amphoteric glycolipids containing a phosphocholine residue from the earthworm Pheretima hilgendorfi.
    Carbohydr Res. [Abstract] [Full-text]
15. Characterization of Chondroitin Sulfate Lyase ABC from Bacteroides thetaiotaomicron WAL2926.
    Biochemistry. [Abstract] [Full-text]
16. Using spectral moments of spiral networks based on PSA/mass spectra outcomes to derive quantitative proteome-disease relationships (QPDRs) and predicting prostate cancer.
    Biochem Biophys Res Commun. [Abstract] [Full-text]
17. Paeonol inhibits RANKL-induced osteoclastogenesis by inhibiting ERK, p38 and NF-kappaB pathway.
    Eur J Pharmacol, 588(1): 124-33. [Abstract] [Full-text]
18. Anti-inflammatory effects of a bioavailable compound, Artepillin C, in Brazilian propolis.
    Eur J Pharmacol, 587(1): 296-301. [Abstract] [Full-text]
19. Curculigo orchioides, a traditional Chinese medicinal plant, prevents bone loss in ovariectomized rats.
    Maturitas, 59(4): 373-80. [Abstract] [Full-text]
20. Anti-inflammatory activity of phylligenin, a lignan from the fruits of Forsythia koreana, and its cellular mechanism of action.
    J Ethnopharmacol, 118(1): 113-7. [Abstract] [Full-text]
21. Morphine-nicotine interaction in conditioned place preference in mice after chronic nicotine exposure.
    Eur J Pharmacol, 587(1): 169-74. [Abstract] [Full-text]
22. Identification of the orphan GPCR, P2Y(10) receptor as the sphingosine-1-phosphate and lysophosphatidic acid receptor.
    Biochem Biophys Res Commun, 371(4): 707-12. [Abstract] [Full-text]
23. Isoliquiritigenin, a flavonoid from licorice, relaxes guinea-pig tracheal smooth muscle in vitro and in vivo: role of cGMP/PKG pathway.
    Eur J Pharmacol, 587(1): 257-66. [Abstract] [Full-text]
24. Effects of harman and norharman on dopamine biosynthesis and L-DOPA-induced cytotoxicity in PC12 cells.
    Eur J Pharmacol, 587(1): 57-64. [Abstract] [Full-text]
25. Halogenated solvent interactions with N,N-dimethyltryptamine: formation of quaternary ammonium salts and their artificially induced rearrangements during analysis.
    Forensic Sci Int, 178(2): 162-70. [Abstract] [Full-text]
26. Stereoselective synthesis of 3,3-diarylacrylonitriles as tubulin polymerization inhibitors.
    J Org Chem, 73(11): 4241-4. [Abstract] [Full-text]
27. Histamine H(4) receptors regulate ACTH release in AtT-20 cells.
    Eur J Pharmacol, 587(1): 336-8. [Abstract] [Full-text]
28. Subacute hypoxia suppresses Kv3.4 channel expression and whole-cell K+ currents through endogenous 15-hydroxyeicosatetraenoic acid in pulmonary arterial smooth muscle cells.
    Eur J Pharmacol, 587(1): 187-95. [Abstract] [Full-text]
29. Quantification of doxazosin in human plasma using hydrophilic interaction liquid chromatography with tandem mass spectrometry.
    J Sep Sci, 31(9): 1628-33. [Abstract] [Full-text]
30. Chromium alleviates glucose intolerance, insulin resistance, and hepatic ER stress in obese mice.
    Obesity (Silver Spring), 16(6): 1331-7. [Abstract] [Full-text]
31. Expression of gLTP in Sympathetic Ganglia from Stress-hypertensive Rats: Molecular Evidence.
    J Mol Neurosci, 35(2): 201-9. [Abstract] [Full-text]
32. Bax Inhibitor-1 Is a pH-dependent Regulator of Ca2+ Channel Activity in the Endoplasmic Reticulum.
    J Biol Chem, 283(23): 15946-15955. [Abstract] [Full-text]
33. Low-temperature synthesis of 2'-deoxyadenosine using immobilized psychrotrophic microorganisms.
    Biotechnol Bioeng, 100(2): 213-22. [Abstract] [Full-text]
34. Nitrile analogs of meperidine as high affinity and selective sigma-1 receptor ligands.
    Eur J Med Chem, 43(6): 1304-8. [Abstract] [Full-text]
35. Early atheroma in primary and secondary antiphospholipid syndrome: an intrinsic finding.
    Semin Arthritis Rheum, 37(6): 373-80. [Abstract] [Full-text]
36. Investigations concerning the COX/5-LOX inhibiting and hydroxyl radical scavenging potencies of novel 4,5-diaryl isoselenazoles.
    Eur J Med Chem, 43(6): 1152-9. [Abstract] [Full-text]
37. The novel primaquine derivatives of N-alkyl, cycloalkyl or aryl urea: Synthesis, cytostatic and antiviral activity evaluations.
    Eur J Med Chem, 43(6): 1180-7. [Abstract] [Full-text]
38. Synthesis of novel 7-benzylamino-2H-1,4-benzoxazin-3(4H)-ones as anticonvulsant agents.
    Eur J Med Chem, 43(6): 1216-21. [Abstract] [Full-text]
39. Xanthine oxidase-activated prodrugs of thymidine phosphorylase inhibitors.
    Eur J Med Chem, 43(6): 1248-60. [Abstract] [Full-text]
40. Non-nucleoside HIV-1 reverse transcriptase inhibitors. Part 11: Structural modulations of diaryltriazines with potent anti-HIV activity.
    Eur J Med Chem, 43(6): 1230-6. [Abstract] [Full-text]
41. Exploration of physicochemical properties and molecular modelling studies of 2-sulfonyl-phenyl-3-phenyl-indole analogs as cyclooxygenase-2 inhibitors.
    Eur J Med Chem, 43(6): 1297-303. [Abstract] [Full-text]
42. In vivo anti-inflammatory and antinociceptive actions of some Lamium species.
    J Ethnopharmacol, 118(1): 166-72. [Abstract] [Full-text]
43. Electromembrane extraction of peptides.
    J Chromatogr A, 1194(2): 143-9. [Abstract] [Full-text]
44. Cognitive-enhancing and antioxidant activities of iridoid glycosides from Scrophularia buergeriana in scopolamine-treated mice.
    Eur J Pharmacol, 588(1): 78-84. [Abstract] [Full-text]
45. Anti-nociceptive activity of aqueous fraction from the MeOH extracts of Paederia scandens in mice.
    J Ethnopharmacol, 118(1): 177-80. [Abstract] [Full-text]
46. 20-Hydroxyeicosatetraenoic acid inhibits the apoptotic responses in pulmonary artery smooth muscle cells.
    Eur J Pharmacol, 588(1): 9-17. [Abstract] [Full-text]
47. The protective effect of eupatilin on indomethacin-induced cell damage in cultured feline ileal smooth muscle cells: involvement of HO-1 and ERK.
    J Ethnopharmacol, 118(1): 94-101. [Abstract] [Full-text]
48. Cytochrome P450 omega hydroxylase (CYP4) function in fatty acid metabolism and metabolic diseases.
    Biochem Pharmacol, 75(12): 2263-75. [Abstract] [Full-text]
49. Efficient synthesis of a sialic acid alpha(2-->3)galactose building block and its application to the synthesis of ganglioside GM3.
    J Org Chem, 73(11): 4287-90. [Abstract] [Full-text]
50. From topical antidote against skin irritants to a novel counter-irritating and anti-inflammatory peptide.
    Toxicol Appl Pharmacol, 229(3): 342-50. [Abstract] [Full-text]
51. Microarray analysis in rat liver slices correctly predicts in vivo hepatotoxicity.
    Toxicol Appl Pharmacol, 229(3): 300-9. [Abstract] [Full-text]
52. Structure formation and characterization of injectable drug loaded biodegradable devices: in situ implants versus in situ microparticles.
    Eur J Pharm Sci, 34(2): 164-72. [Abstract] [Full-text]
53. Targeting of efavirenz loaded tuftsin conjugated poly(propyleneimine) dendrimers to HIV infected macrophages in vitro.
    Eur J Pharm Sci, 34(2): 181-9. [Abstract] [Full-text]
54. Drug permeability across a phospholipid vesicle-based barrier 4. The effect of tensides, co-solvents and pH changes on barrier integrity and on drug permeability.
    Eur J Pharm Sci, 34(2): 173-80. [Abstract] [Full-text]
55. Passive oral drug absorption can be predicted more reliably by experimental than computational models-Fact or myth.
    Eur J Pharm Sci, 34(2): 129-39. [Abstract] [Full-text]
56. Endothelins stimulate the production of stromelysin-1 in cultured rat astrocytes.
    Biochem Biophys Res Commun, 371(4): 659-63. [Abstract] [Full-text]
57. Quality use of medicines: a new method of combining antibiotic consumption and sensitivity data--application in a Russian hospital.
    Pharmacoepidemiol Drug Saf, 17(6): 636-44. [Abstract] [Full-text]
58. Brand substitution or multiple switches per patient? An analysis of pharmaceutical brand substitution in Australia.
    Pharmacoepidemiol Drug Saf, 17(6): 620-5. [Abstract] [Full-text]
59. Influence of antidepressants on glycaemic control in patients with diabetes mellitus.
    Pharmacoepidemiol Drug Saf, 17(6): 577-86. [Abstract] [Full-text]
60. ADAR1 p150 IN ALVEOLAR MACROPHAGE IS INVOLVED IN LPS-INDUCED LUNG INJURY.
    Shock. [Abstract] [Full-text]
61. Paradoxical Elevated Thiopurine S-Methyltransferase Activity After Pancytopenia During Azathioprine Therapy: Potential Influence of Red Blood Cell Age.
    Ther Drug Monit, 30(3): 390-393. [Abstract] [Full-text]
62. A population pharmacokinetic model of epidural lidocaine in geriatric patients: effects of low-dose dopamine.
    Ther Drug Monit, 30(3): 379-89. [Abstract] [Full-text]
63. Assessment of VerifyNow P2Y12 assay accuracy in evaluating clopidogrel-induced platelet inhibition.
    Ther Drug Monit, 30(3): 372-8. [Abstract] [Full-text]
64. Clinical Toxicology of Citalopram After Acute Intoxication With the Sole Drug or in Combination With Other Drugs: Overview of 26 Cases.
    Ther Drug Monit, 30(3): 365-371. [Abstract] [Full-text]
65. High-speed simultaneous determination of nine antiepileptic drugs using liquid chromatography-mass spectrometry.
    Ther Drug Monit, 30(3): 347-56. [Abstract] [Full-text]
66. Development and validation of a high-performance liquid chromatographic assay for the determination of fluconazole in human whole blood using solid phase extraction.
    Ther Drug Monit, 30(3): 314-9. [Abstract] [Full-text]
67. Effects of Cyclosporine A on Single-Dose Pharmacokinetics of Intravenous Itraconazole in Patients With Hematologic Malignancies.
    Ther Drug Monit, 30(3): 301-305. [Abstract] [Full-text]
68. Pharmacokinetics of Mycophenolic Acid and its Phenolic-Glucuronide and Acyl Glucuronide Metabolites in Stable Thoracic Transplant Recipients.
    Ther Drug Monit, 30(3): 282-291. [Abstract] [Full-text]
69. The role of cytochrome P2C19 in R-warfarin pharmacokinetics and its interaction with omeprazole.
    Ther Drug Monit, 30(3): 276-81. [Abstract] [Full-text]
70. 3'-Deoxy-3'-18F-Fluorothymidine as a Proliferation Imaging Tracer for Diagnosis of Lung Tumors: Comparison With 2-Deoxy-2-18F-Fluoro-D-Glucose.
    J Comput Assist Tomogr, 32(3): 432-437. [Abstract] [Full-text]
71. "Get smart Colorado": impact of a mass media campaign to improve community antibiotic use.
    Med Care, 46(6): 597-605. [Abstract] [Full-text]
72. Medicaid Prior Authorization and Controlled-Release Oxycodone.
    Med Care, 46(6): 573-580. [Abstract] [Full-text]
73. Impact of a Medicaid copayment policy on prescription drug and health services utilization in a fee-for-service Medicaid population.
    Med Care, 46(6): 565-72. [Abstract] [Full-text]
74. Incidence, severity and preventability of medication-related visits to the emergency department: a prospective study.
    CMAJ, 178(12): 1563-9. [Abstract] [Full-text]
75. Nitrite Anion Provides Potent Cytoprotective and Antiapoptotic Effects as Adjunctive Therapy to Reperfusion for Acute Myocardial Infarction.
    Circulation. [Abstract] [Full-text]
76. Novel Gene Silencer Pyrrole-Imidazole Polyamide Targeting Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 Attenuates Restenosis of the Artery After Injury.
    Hypertension. [Abstract] [Full-text]
77. A Phase I and Pharmacokinetic Study of Weekly Oxaliplatin Followed by Paclitaxel in Patients with Solid Tumors.
    Clin Cancer Res, 14(11): 3434-3440. [Abstract] [Full-text]
78. Charges and lengths of stay attributable to adverse patient-care events using pediatric-specific quality indicators: a multicenter study of freestanding children's hospitals.
    Pediatrics, 121(6): e1653-9. [Abstract] [Full-text]
79. Initiating and sustaining a standardized pain management program in long-term care facilities.
    J Am Med Dir Assoc, 9(5): 347-53. [Abstract] [Full-text]
80. INHIBITION OF LEFT VENTRICULAR REMODELLING IN SPONTANEOUSLY HYPERTENSIVE RATS by G(alphaq)-PROTEIN CARBOXYL TERMINUS IMITATION POLYPEPTIDE GCIP-27 IS NOT ENTIRELY DEPENDENT ON BLOOD PRESSURE.
    Clin Exp Pharmacol Physiol. [Abstract] [Full-text]
81. Management and control strategies for community-associated methicillin-resistant Staphylococcus aureus.
    Expert Opin Pharmacother, 9(9): 1463-79. [Abstract] [Full-text]
82. When more is not better: treatment intensification among hypertensive patients with poor medication adherence.
    Circulation, 117(22): 2884-92. [Abstract] [Full-text]
83. A sensitive assay for the quantitative analysis of vinorelbine in mouse and human EDTA plasma by high-performance liquid chromatography coupled with electrospray tandem mass spectrometry.
    J Chromatogr B Analyt Technol Biomed Life Sci, 868(1): 102-9. [Abstract] [Full-text]
84. Solid-phase extraction and liquid chromatography/tandem mass spectrometry assay for the determination of pitavastatin in human plasma and urine for application to Phase I clinical pharmacokinetic studies.
    J Chromatogr B Analyt Technol Biomed Life Sci, 868(1): 95-101. [Abstract] [Full-text]
85. Development and validation of a sensitive liquid chromatography/mass spectrometry method for quantitation of flavopiridol in plasma enables accurate estimation of pharmacokinetic parameters with a clinically active dosing schedule.
    J Chromatogr B Analyt Technol Biomed Life Sci, 868(1): 110-5. [Abstract] [Full-text]
86. A sensitive liquid chromatography-mass spectrometry method for simultaneous determination of two active chromones from Saposhnikovia root in rat plasma and urine.
    J Chromatogr B Analyt Technol Biomed Life Sci, 868(1): 13-9. [Abstract] [Full-text]
87. The glucose-lowering agent sodium tungstate increases the levels and translocation of GLUT4 in L6 myotubes through a mechanism associated with ERK1/2 and MEF2D.
    Diabetologia, 51(7): 1285-95. [Abstract] [Full-text]
88. Time-tradeoff utilities for identifying and evaluating a minimum data set for time-critical biosurveillance.
    Med Decis Making, 28(3): 351-8. [Abstract] [Full-text]
89. Cloud point extraction-HPLC method for determination and pharmacokinetic study of flurbiprofen in rat plasma after oral and transdermal administration.
    J Chromatogr B Analyt Technol Biomed Life Sci, 868(1): 64-9. [Abstract] [Full-text]
90. Preparation and characterization of biocompatible oil-loaded polyelectrolyte nanocapsules.
    Nanomedicine, 4(2): 106-14. [Abstract] [Full-text]
91. Liposomal delivery improves the growth-inhibitory and apoptotic activity of low doses of gemcitabine in multiple myeloma cancer cells.
    Nanomedicine, 4(2): 155-66. [Abstract] [Full-text]
92. The Impact of Molecular Weight and PEG Chain Length on the Systemic Pharmacokinetics of PEGylated Poly l-Lysine Dendrimers.
    Mol Pharm, 5(3): 449-463. [Abstract] [Full-text]
93. Preparation and characterization of insulin nanoparticles using chitosan and its quaternized derivatives.
    Nanomedicine, 4(2): 115-20. [Abstract] [Full-text]
94. Risk factors associated with preterm birth according to gestational age at birth.
    Pharmacoepidemiol Drug Saf, 17(6): 556-64. [Abstract] [Full-text]
95. Induction of Cytotoxic T-Lymphocytes and Antitumor Activity by a Liposomal Lipopeptide Vaccine.
    Mol Pharm, 5(3): 464-471. [Abstract] [Full-text]
96. Nuclear-targeted chimeric vector enhancing nonviral gene transfer into skeletal muscle of Fabry mice in vivo.
    FASEB J, 22(6): 2097-107. [Abstract] [Full-text]
97. Oral colon targeted delivery systems for treatment of inflammatory bowel diseases: Synthesis, in vitro and in vivo assessment.
    Int J Pharm, 358(1): 248-55. [Abstract] [Full-text]
98. Site-directed PEGylation as successful approach to improve the enzyme replacement in the case of prolidase.
    Int J Pharm, 358(1): 230-7. [Abstract] [Full-text]
99. Intranasal nanoemulsion based brain targeting drug delivery system of risperidone.
    Int J Pharm, 358(1): 285-91. [Abstract] [Full-text]
100. A comparative study of a range of polymeric microspheres as potential carriers for the inhalation of proteins.
     Int J Pharm, 358(1): 159-67. [Abstract] [Full-text]
101. Formulation of monolayered films with drug and polymers of opposing solubilities.
     Int J Pharm, 358(1): 184-91. [Abstract] [Full-text]
102. Solubilisation of drugs in micellar solutions of diblock copolymers of ethylene oxide and styrene oxide.
     Int J Pharm, 358(1): 303-6. [Abstract] [Full-text]
103. Activity of a sodium-dependent vitamin C transporter (SVCT) in MDCK-MDR1 cells and mechanism of ascorbate uptake.
     Int J Pharm, 358(1): 168-76. [Abstract] [Full-text]
104. Development and evaluation of new sustained-release floating microspheres.
     Int J Pharm, 358(1): 82-90. [Abstract] [Full-text]
105. Paclitaxel tumor biodistribution and efficacy after intratumoral injection of a biodegradable extended release implant.
     Int J Pharm, 358(1): 114-20. [Abstract] [Full-text]
106. Factors influencing hydrocortisone permeation into human hair follicles: Use of the skin sandwich system.
     Int J Pharm, 358(1): 144-50. [Abstract] [Full-text]
107. Physicochemical effects of terpenes on organogel for transdermal drug delivery.
     Int J Pharm, 358(1): 102-7. [Abstract] [Full-text]
108. Improved delivery of cromolyn from oral proliposomal beads.
     Int J Pharm, 358(1): 128-36. [Abstract] [Full-text]
109. Cationic lipid-coated magnetic nanoparticles associated with transferrin for gene delivery.
     Int J Pharm, 358(1): 263-270. [Abstract] [Full-text]
110. Is urbanization a risk factor for substance misuse?
     Curr Opin Psychiatry, 21(4): 391-7. [Abstract] [Full-text]
111. Single-Molecule Studies of Protein Folding.
     Annu Rev Biochem, 77: 101-125. [Abstract] [Full-text]
112. Protein structure modeling indicates hexahistidine-tag interference with enzyme activity.
     Proteins, 72(1): 173-83. [Abstract] [Full-text]
113. Concentrations of resveratrol and derivatives in foods and estimation of dietary intake in a Spanish population: European Prospective Investigation into Cancer and Nutrition (EPIC)-Spain cohort.
     Br J Nutr, 100(1): 188-96. [Abstract] [Full-text]
114. Disparity between prostate tumor interior versus peripheral vasculature in response to verteporfin-mediated vascular-targeting therapy.
     Int J Cancer, 123(3): 695-701. [Abstract] [Full-text]
115. A cost-effectiveness analysis of a community pharmacist-based smoking cessation programme in Thailand.
     Tob Control, 17(3): 177-82. [Abstract] [Full-text]
116. Overview of the Proton-coupled MCT (SLC16A) Family of Transporters: Characterization, Function and Role in the Transport of the Drug of Abuse gamma-Hydroxybutyric Acid.
     AAPS J. [Abstract] [Full-text]
117. Optical methods for measurements of skin penetration.
     Skin Pharmacol Physiol, 21(3): 156-65. [Abstract] [Full-text]
118. Self-medication practices among diabetic patients in Kuwait.
     Med Princ Pract, 17(4): 315-20. [Abstract] [Full-text]
119. Efficacy and Safety of Darusentan: A Novel Endothelin Receptor Antagonist (July/August) (CE).
     Ann Pharmacother. [Abstract] [Full-text]
120. Molecular mechanisms of metastasis.
     Cancer Lett. [Abstract] [Full-text]
121. Seroprevalence of Trypanosoma cruzi infection in at-risk blood donors in Catalonia (Spain).
     Transfusion. [Abstract] [Full-text]
122. Huang-lian-jie-du-tang, a traditional Chinese medicine prescription, induces cell-cycle arrest and apoptosis in human liver cancer cells in vitro and in vivo.
     J Gastroenterol Hepatol. [Abstract] [Full-text]
123. Transcriptional switches in the control of macronutrient metabolism.
     Nutr Rev, 66(6): 321-5. [Abstract] [Full-text]
124. Long-term precision in capillary isoelectric focusing for protein analysis.
     J Sep Sci, 31(10): 1834-40. [Abstract] [Full-text]
125. Dopamine 5 receptor mediates Ang II type 1 receptor degradation via a ubiquitin-proteasome pathway in mice and human cells.
     J Clin Invest, 118(6): 2180-2189. [Abstract] [Full-text]
126. Comparison of analytical methods for the quality control of a new formulation containing soy extract and melatonin.
     J Sep Sci, 31(10): 1851-9. [Abstract] [Full-text]
127. Chemometric, physicomechanical and rheological analysis of the sol-gel dynamics and degree of crosslinking of glycosidic polymers.
     Biomed Mater, 3(2): 25003. [Abstract] [Full-text]
128. Flux across of microneedle-treated skin is increased by increasing charge of naltrexone and naltrexol in vitro.
     Pharm Res, 25(7): 1677-85. [Abstract] [Full-text]
129. Pharmacokinetics of low and maintenance dose valganciclovir in kidney transplant recipients.
     Am J Transplant, 8(6): 1297-302. [Abstract] [Full-text]
130. Characterization of the mechanism of zidovudine uptake by rat conditionally immortalized syncytiotrophoblast cell line TR-TBT.
     Pharm Res, 25(7): 1647-53. [Abstract] [Full-text]
131. Evaluation of the pharmacokinetics of all-trans-retinoic acid (ATRA) in Wistar rats after intravenous administration of ATRA loaded into tributyrin submicron emulsion and its cellular activity on caco-2 and HepG2 cell lines.
     J Pharm Sci, 97(7): 2844-53. [Abstract] [Full-text]
132. Cytotoxicity and apoptosis enhancement in brain tumor cells upon coadministration of paclitaxel and ceramide in nanoemulsion formulations.
     J Pharm Sci, 97(7): 2745-56. [Abstract] [Full-text]
133. Synthesis and in vitro characterization of novel dextran-methylprednisolone conjugates with peptide linkers: effects of linker length on hydrolytic and enzymatic release of methylprednisolone and its peptidyl intermediates.
     J Pharm Sci, 97(7): 2649-64. [Abstract] [Full-text]
134. Pharmacokinetic/pharmacodynamic modeling of corticosterone suppression and lymphocytopenia by methylprednisolone in rats.
     J Pharm Sci, 97(7): 2820-32. [Abstract] [Full-text]
135. Plant-derived natural product research aimed at new drug discovery.
     Nat Med (Tokyo), 62(3): 263-80. [Abstract] [Full-text]
136. Investigation on bioavailability of some essential and toxic elements in medicinal herbs.
     Nat Med (Tokyo), 62(3): 340-4. [Abstract] [Full-text]
137. Antioxidant and hepatoprotective activity of the methanol extract of Careya arborea bark in Ehrlich ascites carcinoma-bearing mice.
     Nat Med (Tokyo), 62(3): 336-9. [Abstract] [Full-text]
138. Intravesical treatments of bladder cancer: review.
     Pharm Res, 25(7): 1500-10. [Abstract] [Full-text]
139. What is a suitable dissolution method for drug nanoparticles?
     Pharm Res, 25(7): 1696-701. [Abstract] [Full-text]
140. Evaluation of direct transport pathways of glycine receptor antagonists and an angiotensin antagonist from the nasal cavity to the central nervous system in the rat model.
     Pharm Res, 25(7): 1531-43. [Abstract] [Full-text]
141. The role of fines in the modification of the fluidization and dispersion mechanism within dry powder inhaler formulations.
     Pharm Res, 25(7): 1631-40. [Abstract] [Full-text]
142. Formulating poly(lactide-co-glycolide) particles for plasmid DNA delivery.
     J Pharm Sci, 97(7): 2448-61. [Abstract] [Full-text]
143. Skin peptides: biological activity and therapeutic opportunities.
     J Pharm Sci, 97(7): 2524-42. [Abstract] [Full-text]
144. Studies on the crystal forms of pefloxacin: preparation, characterization, and dissolution profile.
     J Pharm Sci, 97(7): 2637-48. [Abstract] [Full-text]
145. The development of heated tip force-distance measurements as a novel approach to site-specific characterization of pharmaceutical materials.
     J Pharm Sci, 97(7): 2768-79. [Abstract] [Full-text]
146. 7-Nitroindazole, nitric oxide synthase inhibitor, attenuates physical dependence on butorphanol in rat.
     Synapse, 62(8): 582-9. [Abstract] [Full-text]
147. Where do we go now with low molecular weight heparin use in obstetric care? A review for the Journal of Thrombosis & Haemostasis.
     J Thromb Haemost. [Abstract] [Full-text]
148. Systems for region selective drug delivery in the gastrointestinal tract: biopharmaceutical considerations.
     Expert Opin Drug Deliv, 5(6): 681-692. [Abstract] [Full-text]
149. Novel vesicular and particulate drug delivery systems for topical treatment of acne.
     Expert Opin Drug Deliv, 5(6): 665-79. [Abstract] [Full-text]
150. Analysis of initial burst in PLGA microparticles.
     Expert Opin Drug Deliv, 5(6): 615-28. [Abstract] [Full-text]
151. Preparation of 99m Tc-MAG3: the effect on radiochemical purity of using sodium chloride injection from plastic ampoules that have been exposed to light.
     Nucl Med Commun, 29(7): 649-53. [Abstract] [Full-text]
152. Radioactivity concentrations in sediments on the coast of the Iranian province of Khuzestan in the Northern Persian Gulf.
     Environ Toxicol. [Abstract] [Full-text]
153. Supercritical Extraction of Carotenoids from Rosa canina L. Hips and their Formulation with beta-Cyclodextrin.
     AAPS PharmSciTech. [Abstract] [Full-text]
154. Metallothionein attenuates carmustine-induced oxidative stress and protects against pulmonary fibrosis in rats.
     Arch Toxicol. [Abstract] [Full-text]
155. The Protective and Antidotal Effects of Taurine on Hexavalent Chromium-Induced Oxidative Stress in Mice Liver Tissue.
     Biol Trace Elem Res. [Abstract] [Full-text]
156. Organocatalysis: asymmetric cascade reactions catalysed by chiral secondary amines.
     Org Biomol Chem, 6(12): 2037-46. [Abstract] [Full-text]
157. The Effect of Atazanavir and Atazanavir/Ritonavir on UDP-Glucuronosyltransferase Using Lamotrigine as a Phenotypic Probe.
     Clin Pharmacol Ther. [Abstract] [Full-text]
158. Effect of aprepitant on intravenous tacrolimus disposition in reduced intensity hematopoietic stem cell transplantation.
     J Oncol Pharm Pract. [Abstract] [Full-text]
159. The use and effectiveness of granulocyte colony-stimulating factor in primary prophylaxis for febrile neutropenia in the outpatient setting.
     J Oncol Pharm Pract. [Abstract] [Full-text]
160. Design, synthesis and biological evaluation of novel fluorinated docetaxel analogues.
     Eur J Med Chem. [Abstract] [Full-text]
161. Design, synthesis and characterization of N(9)/N(7)-substituted 6-aminopurines as VEGF-R and EGF-R inhibitors.
     Eur J Med Chem. [Abstract] [Full-text]
162. Synthesis, optimization and structure-activity relationships of 3,5-disubstituted isoxazolines as new anti-tuberculosis agents.
     Eur J Med Chem. [Abstract] [Full-text]
163. Synthesis, biological evaluation and 2D-QSAR analysis of benzoxazoles as antimicrobial agents.
     Eur J Med Chem. [Abstract] [Full-text]
164. Functional significance of axonal Kv7 channels in hippocampal pyramidal neurons.
     Proc Natl Acad Sci U S A, 105(22): 7869-74. [Abstract] [Full-text]
165. Heterologous production of secondary metabolites as pharmaceuticals in Saccharomyces cerevisiae.
     Biotechnol Lett, 30(7): 1121-37. [Abstract] [Full-text]
166. Plectin 1 links intermediate filaments to costameric sarcolemma through {beta}-synemin, {alpha}-dystrobrevin and actin.
     J Cell Sci, 121: 2062-74. [Abstract] [Full-text]
167. Nitric oxide-A novel therapeutic for cancer.
     Nitric Oxide. [Abstract] [Full-text]
168. Flavonoids and terpenoids from Helichrysum forskahlii.
     Phytochemistry, 69(9): 1910-4. [Abstract] [Full-text]
169. Synthesis and anticonvulsant activity of aromatic tetramethylcyclopropanecarboxamide derivatives.
     Bioorg Med Chem, 16(11): 6297-305. [Abstract] [Full-text]
170. High specific activity tritium-labeled N-(2-methoxybenzyl)-2,5-dimethoxy-4-iodophenethylamine (INBMeO): A high-affinity 5-HT2A receptor-selective agonist radioligand.
     Bioorg Med Chem, 16(11): 6116-23. [Abstract] [Full-text]
171. Synthesis and in vitro evaluation of a library of modified endomorphin 1 peptides.
     Bioorg Med Chem, 16(11): 6286-96. [Abstract] [Full-text]
172. Novel 3-carboxamide-coumarins as potent and selective FXIIa inhibitors.
     J Med Chem, 51(11): 3077-80. [Abstract] [Full-text]
173. Triterpene saponins from Chenopodium quinoa Willd.
     Phytochemistry, 69(9): 1919-1926. [Abstract] [Full-text]
174. E,E-2-Benzylidene-6-(nitrobenzylidene)cyclohexanones: Syntheses, cytotoxicity and an examination of some of their electronic, steric, and hydrophobic properties.
     Bioorg Med Chem, 16(11): 6261-8. [Abstract] [Full-text]
175. Guaianolide sesquiterpenes from Pulicariacrispa (Forssk.) Oliv.
     Phytochemistry, 69(9): 1915-8. [Abstract] [Full-text]
176. Anti-HIV-1 protease triterpenoids from Stauntonia obovatifoliola Hayata subsp. intermedia.
     Phytochemistry, 69(9): 1875-9. [Abstract] [Full-text]
177. Correlation of in vitro and in vivo models for the oral absorption of peptide drugs.
     Amino Acids, 35(1): 233-41. [Abstract] [Full-text]
178. The effects of sulfur-containing compounds and gemcitabine on the binding of cisplatin to plasma proteins and DNA determined by inductively coupled plasma mass spectrometry and high performance liquid chromatography-inductively coupled plasma mass spectrometry.
     Anticancer Drugs, 19(6): 621-30. [Abstract] [Full-text]
179. Synthesis and viscoelastic characterization of novel hydrogels generated via photopolymerization of 1,2-epoxy-5-hexene modified poly(vinyl alcohol) for use in tissue replacement.
     Acta Biomater, 4(4): 967-75. [Abstract] [Full-text]
180. Enhanced transdermal delivery of a dipeptide by Dermaportation.
     Biopolymers. [Abstract] [Full-text]
181. Access to essential drugs in Guyana: a public health challenge.
     Int J Health Plann Manage. [Abstract] [Full-text]
182. Apolipoprotein A-I attenuates renal ischemia/reperfusion injury in rats.
     J Biomed Sci. [Abstract] [Full-text]
183. Carbohydrate and steroid analysis by desorption electrospray ionization mass spectrometry.
     Chem Commun (Camb). [Abstract] [Full-text]
184. More choices than ever before: emerging therapies for type 2 diabetes.
     Diabetes Educ, 34(3): 518-34. [Abstract] [Full-text]
185. Optimal vaccination schedules using Simulated Annealing.
     Bioinformatics. [Abstract] [Full-text]
186. Evaluation of the local anaesthetic activity of 3-aminobenzo[d]isothiazole derivatives using the rat sciatic nerve model.
     Eur J Med Chem. [Abstract] [Full-text]
187. The symptom mitigation path of mobile community residents: Community pharmacy's role.
     Health Policy. [Abstract] [Full-text]
188. Ultrasound in phage display: a new approach to nonspecific elution.
     Biotechniques, 44(7): 893-900. [Abstract] [Full-text]
189. Cholesterol domains in cationic lipid/DNA complexes improve transfection.
     Biochim Biophys Acta. [Abstract] [Full-text]
190. Antitumor agents 260. New desmosdumotin B analogues with improved in vitro anticancer activity.
     J Med Chem, 51(11): 3297-303. [Abstract] [Full-text]
191. Antipsychotic drug action: antagonism, inverse agonism or partial agonism.
     Trends Pharmacol Sci, 29(6): 314-21. [Abstract] [Full-text]
192. mRNA-display-based selections for proteins with desired functions: a protease-substrate case study.
     Biotechnol Prog, 24(3): 561-9. [Abstract] [Full-text]
193. Trifluoromethoxyl substituted phenylethylene diamines as high affinity sigma receptor ligands with potent anti-cocaine actions.
     J Med Chem, 51(11): 3322-5. [Abstract] [Full-text]
194. Bromocriptine activates NQO1 via Nrf2-PI3K/Akt signaling: Novel cytoprotective mechanism against oxidative damage.
     Pharmacol Res, 57(5): 325-31. [Abstract] [Full-text]
195. High-throughput gender identification of Accipitridae eagles with real-time PCR using TaqMan probes.
     Theriogenology, 70(1): 83-90. [Abstract] [Full-text]
196. Cyclin-dependent kinase 9: a key transcriptional regulator and potential drug target in oncology, virology and cardiology.
     Trends Pharmacol Sci, 29(6): 302-13. [Abstract] [Full-text]
197. Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
     J Med Chem, 51(11): 3275-87. [Abstract] [Full-text]
198. The chemical biology of nitric oxide: implications in cellular signaling.
     Free Radic Biol Med, 45(1): 18-31. [Abstract] [Full-text]
199. What do different databases tell about the use of opioids in seven European countries in 2002?
     Eur J Pain, 12(6): 705-15. [Abstract] [Full-text]
200. Evaluation of a novel educational strategy, including inhaler-based reminder labels, to improve asthma inhaler technique.
     Patient Educ Couns, 72(1): 26-33. [Abstract] [Full-text]
201. Characterization of single and double inactivation strains reveals new physiological roles for group 2 sigma factors in the cyanobacterium Synechocystis sp. PCC 6803.
     Plant Physiol. [Abstract] [Full-text]
202. Medication use after bariatric surgery in a managed care cohort.
     Surg Obes Relat Dis. [Abstract] [Full-text]
203. Influence of crystal hydration on the mechanical properties of sodium naproxen.
     Eur J Pharm Biopharm. [Abstract] [Full-text]
204. Characterization of the pTZ2162 encoding multidrug efflux gene qacB from Staphylococcus aureus.
     Plasmid. [Abstract] [Full-text]
205. Increased expression of Nrf2/ARE-dependent anti-oxidant proteins in tamoxifen-resistant breast cancer cells.
     Free Radic Biol Med. [Abstract] [Full-text]
206. The phytoestrogenic isoflavones from Trifolium pratense L. (Red clover) protects human cortical neurons from glutamate toxicity.
     Phytomedicine. [Abstract] [Full-text]
207. Cytotoxic effects of hyperatomarin, a prenylated phloroglucinol from Hypericum annulatum Moris subsp. annulatum, in a panel of malignant cell lines.
     Phytomedicine. [Abstract] [Full-text]
208. Multi-functional nanocarriers for targeted delivery of drugs and genes.
     J Control Release. [Abstract] [Full-text]
209. The cytotoxicity and genotoxicity of okadaic acid are cell-line dependent.
     Toxicon, 51(8): 1338-44. [Abstract] [Full-text]
210. In vitro evaluation of antibacterial, antioxidant, cytotoxic and apoptotic activities of the tubers infusion and extracts of Cyperus rotundus.
     Bioresour Technol. [Abstract] [Full-text]
211. Increase in antiepileptic efficacy during prolonged treatment with valproic acid: Role of inhibition of histone deacetylases?
     Epilepsy Res. [Abstract] [Full-text]
212. Multi-functional nanocarriers to overcome tumor drug resistance.
     Cancer Treat Rev. [Abstract] [Full-text]
213. Enantioseparation of dopa and related compounds by cyclodextrin-modified microemulsion electrokinetic chromatography.
     J Chromatogr A. [Abstract] [Full-text]
214. Does a physician's specialty influence the recording of medication history in patients' case notes?
     Br J Clin Pharmacol. [Abstract] [Full-text]
215. Thrombocytopenia in Patients Treated with Heparin, Combination Antiplatelet Therapy, and Intra-Aortic Balloon Pump Counterpulsation.
     J Interv Cardiol. [Abstract] [Full-text]
216. Emerging lipid-lowering drugs: squalene synthase inhibitors.
     Expert Opin Emerg Drugs, 13(2): 309-22. [Abstract] [Full-text]
217. Anti-infectives clinical progress of HIV-1 integrase inhibitors.
     Expert Opin Emerg Drugs, 13(2): 213-25. [Abstract] [Full-text]
218. Better to be red than blue in virtual competition.
     Cyberpsychol Behav, 11(3): 375-7. [Abstract] [Full-text]
219. Gender and age differences in medications dispensed from a national chain drugstore.
     J Womens Health (Larchmt), 17(5): 735-43. [Abstract] [Full-text]
220. Stereospecific effects of benzo[d]isothiazolyloxypropanolamine derivatives at beta-adrenoceptors: Synthesis, chiral resolution, and biological activity in vitro.
     Chirality. [Abstract] [Full-text]
221. Mechanisms of Cancer Chemopreventive Agents: A Perspective.
     Planta Med. [Abstract] [Full-text]
222. Anthracycline toxicity to cardiomyocytes or cancer cells is differently affected by iron chelation with salicylaldehyde isonicotinoyl hydrazone.
     Br J Pharmacol. [Abstract] [Full-text]
223. Bovine glycomacropeptide ameliorates experimental rat ileitis by mechanisms involving downregulation of interleukin 17.
     Br J Pharmacol, 154(4): 825-32. [Abstract] [Full-text]
224. Withdrawal-like behavior in planarians is dependent on drug exposure duration.
     Neurosci Lett, 439(1): 84-8. [Abstract] [Full-text]
225. Improving off-line accelerated tryptic digestion. Towards fast-lane proteolysis of complex biological samples.
     J Chromatogr A, 1195(1): 34-43. [Abstract] [Full-text]
226. HV-BBI--a novel amphibian skin Bowman-Birk-like trypsin inhibitor.
     Biochem Biophys Res Commun, 372(1): 191-6. [Abstract] [Full-text]
227. Zinc-binding activity of different pectin compounds in aqueous solutions.
     J Colloid Interface Sci, 323(2): 216-22. [Abstract] [Full-text]
228. A Liquid Chromatography-Quadrupole Time-of-Flight (LC-QTOF)-based Metabolomic Approach Reveals New Metabolic Effects of Catechin in Rats Fed High-Fat Diets.
     J Proteome Res, 7(6): 2388-2398. [Abstract] [Full-text]
229. Exploration of the intercellular heterogeneity of topotecan uptake into human breast cancer cells through compartmental modelling.
     Math Biosci, 213(2): 119-34. [Abstract] [Full-text]
230. Cinnamoyl-based Nrf2-activators targeting human skin cell photo-oxidative stress.
     Free Radic Biol Med. [Abstract] [Full-text]
231. The potent vasodilator ethyl nitrite is formed upon reaction of nitrite and ethanol under gastric conditions.
     Free Radic Biol Med. [Abstract] [Full-text]
232. Chitosan-carboxymethylcellulose interpolymer complexes for gastric-specific delivery of clarithromycin.
     Int J Pharm, 359(1): 135-43. [Abstract] [Full-text]
233. Nociceptin attenuates methamphetamine abstinence-induced withdrawal-like behavior in planarians.
     Neuropeptides, 42(3): 229-37. [Abstract] [Full-text]
234. Inhalable large porous microspheres of low molecular weight heparin: in vitro and in vivo evaluation.
     J Control Release, 128(3): 224-32. [Abstract] [Full-text]
235. Ocular pharmacokinetics of acyclovir amino acid ester prodrugs in the anterior chamber: evaluation of their utility in treating ocular HSV infections.
     Int J Pharm, 359(1): 15-24. [Abstract] [Full-text]
236. Glycyrrhizin surface-modified chitosan nanoparticles for hepatocyte-targeted delivery.
     Int J Pharm, 359(1): 247-53. [Abstract] [Full-text]
237. Butyl 4-(butyryloxy)benzoate functions as a new selective estrogen receptor beta agonist and induces GLUT4 expression in CHO-K1 cells.
     J Steroid Biochem Mol Biol, 110(1): 150-6. [Abstract] [Full-text]
238. A novel mathematical model quantifying drug release from lipid implants.
     J Control Release, 128(3): 233-40. [Abstract] [Full-text]
239. Administration of Lactobacillus casei and Lactobacillus plantarum affects the diversity of murine intestinal lactobacilli, but not the overall bacterial community structure.
     Res Microbiol, 159(4): 237-43. [Abstract] [Full-text]
240. The CCK-system underpins novelty-seeking behavior in the rat: Gene expression and pharmacological analyses.
     Neuropeptides, 42(3): 245-53. [Abstract] [Full-text]
241. Asthma exacerbations during the first trimester of pregnancy and the risk of congenital malformations among asthmatic women.
     J Allergy Clin Immunol, 121(6): 1379-84, 1384.e1. [Abstract] [Full-text]
242. Synthesis, biochemical evaluation of a range of potent 4-substituted phenyl alkyl imidazole-based inhibitors of the enzyme complex 17alpha-Hydroxylase/17,20-Lyase (P450(17alpha)).
     J Steroid Biochem Mol Biol, 110(1): 18-29. [Abstract] [Full-text]
243. Sulfur-containing malodorant vapors enhance responsiveness to the sensory irritant capsaicin.
     Toxicol Sci, 104(1): 198-209. [Abstract] [Full-text]
244. Sexual dimorphism in rabbit aortic endothelial function under acute hyperglycemic conditions and gender-specific responses to acute 17beta-estradiol.
     Am J Physiol Heart Circ Physiol, 294(6): H2411-20. [Abstract] [Full-text]
245. Quantum-chemical foundations of the topological substructural molecular design.
     J Phys Chem A, 112(23): 5208-17. [Abstract] [Full-text]
246. Preparation and characterization of PE38KDEL-loaded anti-HER2 nanoparticles for targeted cancer therapy.
     J Control Release, 128(3): 209-16. [Abstract] [Full-text]
247. The validity of self-reported prescription medication use among adolescents varied by therapeutic class.
     J Clin Epidemiol, 61(7): 714-7. [Abstract] [Full-text]
248. Gene expression profiles of murine fatty liver induced by the administration of methotrexate.
     Toxicology, 249(1): 75-84. [Abstract] [Full-text]
249. Comparative pharmacokinetics of breviscapine liposomes in dogs, rabbits and rats.
     Int J Pharm, 359(1): 118-22. [Abstract] [Full-text]
250. Toxicology and pharmacokinetics of piperaquine in mice.
     Toxicology, 249(1): 55-61. [Abstract] [Full-text]
251. Physicochemical properties and oral bioavailability of amorphous atorvastatin hemi-calcium using spray-drying and SAS process.
     Int J Pharm, 359(1): 211-9. [Abstract] [Full-text]
252. Nimodipine semi-solid capsules containing solid dispersion for improving dissolution.
     Int J Pharm, 359(1): 144-9. [Abstract] [Full-text]
253. Wax-based sustained release matrix pellets prepared by a novel freeze pelletization technique I. Formulation and process variables affecting pellet characteristics.
     Int J Pharm, 359(1): 158-66. [Abstract] [Full-text]
254. Wax-based sustained release matrix pellets prepared by a novel freeze pelletization technique II. In vitro drug release studies and release mechanisms.
     Int J Pharm, 359(1): 167-73. [Abstract] [Full-text]
255. Microwave-assisted drying of pharmaceutical granules and its impact on drug stability.
     Int J Pharm, 359(1): 53-62. [Abstract] [Full-text]
256. Peptide prodrugs: improved oral absorption of lopinavir, a HIV protease inhibitor.
     Int J Pharm, 359(1): 7-14. [Abstract] [Full-text]
257. Rumen bypass and biodistribution of l-carnitine from dual-layered coated pellets in cows, in vitro and in vivo.
     Int J Pharm, 359(1): 87-93. [Abstract] [Full-text]
258. Angiotensin II increases GABAB receptor expression in nucleus tractus solitarii of rats.
     Am J Physiol Heart Circ Physiol, 294(6): H2712-20. [Abstract] [Full-text]
259. Effect of chronic and selective endothelin receptor antagonism on microvascular function in Type 2 diabetes.
     Am J Physiol Heart Circ Physiol, 294(6): H2743-9. [Abstract] [Full-text]
260. Ghrelin improves burn-induced multiple organ injury by depressing neutrophil infiltration and the release of pro-inflammatory cytokines.
     Peptides, 29(7): 1231-40. [Abstract] [Full-text]
261. NMR study of 5-substituted pyrazolo[3,4-c]pyridine derivatives.
     Magn Reson Chem, 46(7): 643-9. [Abstract] [Full-text]
262. Analysis of carboxyl tail function in the skeletal muscle Cl- channel hClC-1.
     Biochem J, 413(1): 61-9. [Abstract] [Full-text]
263. Kinetic, thermodynamic and X-ray structural insights into the interaction of melatonin and analogues with quinone reductase 2.
     Biochem J, 413(1): 81-91. [Abstract] [Full-text]
264. Toxic effects of arsenic on Sinorhizobium-Medicago sativa symbiotic interaction.
     Environ Pollut, 154(2): 203-11. [Abstract] [Full-text]
265. Enhanced luminescence of rare-earth complexes Tb(1-x)Eu(x)(m-NBA)(3)Phen in ZnS.
     Spectrochim Acta A Mol Biomol Spectrosc, 70(2): 253-7. [Abstract] [Full-text]
266. Catanionic aggregates formed from drugs and lauric or capric acids enable prolonged release from gels.
     J Colloid Interface Sci, 323(2): 386-94. [Abstract] [Full-text]
267. Actions of 3,4-methylenedioxymethamphetamine (MDMA) on cerebral dopaminergic, serotonergic and cholinergic neurons.
     Pharmacol Biochem Behav, 90(2): 198-207. [Abstract] [Full-text]
268. Microdialysis of GABA and glutamate: analysis, interpretation and comparison with microsensors.
     Pharmacol Biochem Behav, 90(2): 135-47. [Abstract] [Full-text]
269. IKKbeta/NF-kappaB and the miscreant macrophage.
     J Exp Med, 205(6): 1255-9. [Abstract] [Full-text]
270. 1-[4-(2-Aminoethoxy)phenylcarbonyl]-3,5-bis-(benzylidene)-4-oxopiperidines: a novel series of highly potent revertants of P-glycoprotein associated multidrug resistance.
     Bioorg Med Chem Lett, 18(12): 3484-7. [Abstract] [Full-text]
271. Facile formation of hydrophilic derivatives of 5H-8,9-dimethoxy-5-[2-(N,N-dimethylamino)ethyl]-2,3-methylenedioxydibenzo[c,h] [1,6]naphthyridin-6-one (ARC-111) and its 12-aza analog via quaternary ammonium intermediates.
     Bioorg Med Chem Lett, 18(12): 3570-2. [Abstract] [Full-text]
272. Complete sequence of Enterococcus faecium pVEF3 and the detection of an omega-epsilon-zeta toxin-antitoxin module and an ABC transporter.
     Plasmid, 60(1): 75-85. [Abstract] [Full-text]
273. Oxaliplatin-DNA adduct formation in white blood cells of cancer patients.
     Br J Cancer, 98(12): 1959-65. [Abstract] [Full-text]
274. Phase I pharmacokinetic and pharmacodynamic study of the prenyl transferase inhibitor AZD3409 in patients with advanced cancer.
     Br J Cancer, 98(12): 1951-8. [Abstract] [Full-text]
275. Identification of HDM2 as a regulator of VEGF expression in cancer cells.
     Life Sci, 82(25): 1231-41. [Abstract] [Full-text]
276. Opioids and efflux transporters. Part 3: P-glycoprotein substrate activity of 3-hydroxyl addition to meperidine analogs.
     Bioorg Med Chem Lett, 18(12): 3638-40. [Abstract] [Full-text]
277. Silymarin prevents adriamycin-induced cardiotoxicity and nephrotoxicity in rats.
     Food Chem Toxicol, 46(7): 2422-8. [Abstract] [Full-text]
278. Monoglycerides from the brown alga Sargassum sagamianum: Isolation, synthesis, and biological activity.
     Bioorg Med Chem Lett, 18(12): 3589-92. [Abstract] [Full-text]
279. pH-Dependent Assembly of Hybrids Based on Wells-Dawson POM/Ag Chemistry.
     Inorg Chem, 47(12): 5145-5153. [Abstract] [Full-text]
280. Drug release and swelling kinetics of directly compressed glipizide sustained-release matrices: establishment of level A IVIVC.
     J Control Release, 129(1): 49-58. [Abstract] [Full-text]
281. Solid lipid nanoparticles loading adefovir dipivoxil for antiviral therapy.
     J Zhejiang Univ Sci B, 9(6): 506-10. [Abstract] [Full-text]
282. Piroxicam/2-hydroxypropyl-beta-cyclodextrin inclusion complex prepared by a new fluid-bed coating technique.
     J Pharm Sci. [Abstract] [Full-text]
283. Techniques to develop and characterize nanosized formulation for salbutamol sulfate.
     J Mater Sci Mater Med. [Abstract] [Full-text]
284. Cyclooxygenase selectivity of nonsteroidal anti-inflammatory drugs and risk of stroke.
     Arch Intern Med, 168(11): 1219-24. [Abstract] [Full-text]
285. Point Mutation in the Group B Streptococcal pbp2x Gene Conferring Decreased Susceptibility to Beta-Lactam Antibiotics.
     Antimicrob Agents Chemother. [Abstract] [Full-text]
286. Optimizing patient safety by preventing combined use of intramuscular olanzapine and parenteral benzodiazepines.
     Am J Health Syst Pharm, 65(12): 1180-3. [Abstract] [Full-text]
287. Adverse-drug-reaction reporting by pharmacy students in a teaching hospital.
     Am J Health Syst Pharm, 65(12): 1177-9. [Abstract] [Full-text]
288. Sterilization of glycerin.
     Am J Health Syst Pharm, 65(12): 1173-6. [Abstract] [Full-text]
289. Economic effects of clinical pharmacy interventions: a literature review.
     Am J Health Syst Pharm, 65(12): 1161-72. [Abstract] [Full-text]
290. Risk factors for ovarian hyperstimulation syndrome in Thai patients using gonadotropins for in vitro fertilization.
     Am J Health Syst Pharm, 65(12): 1148-53. [Abstract] [Full-text]
291. Heparin-induced thrombocytopenia complicated by warfarin-induced skin necrosis.
     Am J Health Syst Pharm, 65(12): 1144-7. [Abstract] [Full-text]
292. A sphingosine kinase activity assay using direct infusion electrospray ionization tandem mass spectrometry.
     Anal Biochem. [Abstract] [Full-text]
293. Characterization of exopolysaccharides produced by three moderately halophilic bacteria belonging to the family Alteromonadaceae.
     J Appl Microbiol. [Abstract] [Full-text]
294. Simultaneous determination of dopamine, ascorbic acid and uric acid at poly (Evans Blue) modified glassy carbon electrode.
     Bioelectrochemistry, 73(1): 11-7. [Abstract] [Full-text]
295. Cardiac overexpression of alcohol dehydrogenase exacerbates chronic ethanol ingestion-induced myocardial dysfunction and hypertrophy: role of insulin signaling and ER stress.
     J Mol Cell Cardiol, 44(6): 992-1001. [Abstract] [Full-text]
296. Influence of extended-spectrum beta-lactams on gram-negative bacterial resistance.
     Am J Health Syst Pharm, 65(12): 1154-9. [Abstract] [Full-text]